The hardware upgrades more than “double the effective horsepower of DUG’s Houston data center.” Photo via dug.com

An Australia-based company has launched a major upgrade of its Houston data center with sustainability in mind.

DUG Technology announced it's increased the company’s high performance computing (HPC) capabilities and also reinforced its commitment to sustainable innovative technology. The company announced its latest investment in 1500 new AMD EPYCTM Genoa servers, which has 192 cores and 1.5 terabytes of DDR5 memory each. Quebec-based IT solution company Hypertec provided the immersion-born hardware.

“DUG’s decision highlights the unmatched technological advancements and superior performance of Hypertec immersion-born products, which are setting a new benchmark in the industry,” Hypertec’s Patrick Scateni, vice president of global sales says in a news release.

Recently, DUG deployed 600 new Intel Xeon CPU Max Series machines, which are equipped with 128 cores and one terabyte of RAM. All of their existing servers had a RAM upgrade to 384 gigabytes. The hardware upgrades more than “double the effective horsepower of DUG’s Houston data center,” according to the company.

DUG initially started construction on Bubba in 2018, and chose Skybox Datacenters as the facility to put Bubba in after a global search. The supercomputer landing in Houston represented the largest data center transaction in the Houston area's history with Dallas-Fort Worth, Austin, and San Antonio having previously overshadowed Houston as hotspots for data center activity in the state.

“Houston was a natural choice," DUG’s Managing Director Matthew Lamont previously told InnovationMap. “Given the low cost of power and the fact that Skybox had the available infrastructure ready to go."

DUG’s Houston facility was the DCD Awards winner of the 2019 Enterprise Data Centre Design Award. The upgrade of DUG’s Houston-based supercomputer Bubba was opened with a ribbon-cutting ceremony by the Hon Stephen Dawson MLA, Minister for Emergency Services; Innovation and the Digital Economy; Science; Medical Research, during his “Western Australia: USA Connect” mission to the United States.

Also present for the announcement was Christopher Skeete, Minister for the Economy in the National Assembly of Québec. DUG joined the Western Australia (WA) trade delegation to Texas, led by Minister Dawson. The trade delegation looks to establish strategic connections through investment and trade with WA with a focus on the energy transition and green technology.

“It is very exciting to see our HPC capabilities scale in response to the increasing demand for our technology,” Lamont says in the release. “The new hardware was purchased after extensive testing and our partners were chosen based on the unparalleled performance of their solutions. The Intel machines are already turbocharging our new MP-FWI Imaging technology, which is having a transformative impact on the way we process seismic data.

"Delivering unsurpassed imaging with rapid turnaround for our clients, it is a complete replacement for the conventional processing and imaging workflow," he continued. "The new Hypertec-supplied AMD machines are needed to accelerate delivery of both current and imminent projects, and to support the unprecedented demand we continue to see moving forward.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.